1. 1. Kimura, K., Nagano, N., Nagano, Y., Suzuki S.High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J. Antimicrob. Chemother., 2012; doi:10.1093/jac/dks423.
2. 2. Lu, B., Li, D., Cui, Y., Sui, W., Huang, L., Lu, X. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clin. Microbiol. Infect. 2014; 20: 370-3.
3. 3. Verani, J.R., McGee, L., Schrag, S.J. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease revised guidelines from CDC. MMWR. Recomm. Rep., 2010; 59: 1-36.
4. 4. Rodriguez-Granger, J., Alvargonzalez, J.C., Berardi, A., Berner, R., Kunze, M., Hufnagel, M., Melin, P., et al. Prevention of group B streptococcal neonatal disease revisited. Eur. J. Clin. Microbiol. Infect.Dis., 2012; 31: 2097-2104.
5. 5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty fifth Informational Supplement M100-S25. CLSI, Wayne, PA, USA, 2015.